Neogen (NEOG) Total Debt Growth (3y) (2014 - 2026)
Neogen (NEOG) Total Debt Growth (3y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | 24.63% |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 4.89% |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 4.70% |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 11.72% |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 0.11% |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | -0.47% |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | -1.01% |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | -13.48% |
| 10 | Neogen | 2.61 Bn | 2.42 Bn | 107.80 Mn | -3.58% |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | -3.58% |
| Feb 28, 2026 | -3.57% |
| Nov 30, 2025 | -4.97% |
| Feb 28, 2017 | 12.89% |
| Nov 30, 2016 | 1.32% |
| Aug 31, 2016 | 1.50% |
| May 31, 2016 | 4.83% |
| Feb 29, 2016 | 1.13% |
| Nov 30, 2015 | -9.38% |
| Aug 31, 2015 | -7.53% |
| May 31, 2015 | -7.52% |
| Feb 28, 2015 | -22.89% |
| Nov 30, 2014 | -22.36% |
| Aug 31, 2014 | -23.03% |
| May 31, 2014 | -25.48% |